Alpha 2.0
Login Register
» Authors » Kyoko Katsumata

Kyoko Katsumata

Explore the profile of Kyoko Katsumata including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 97
Followers 0
Related Specialties
Nephrology
General Surgery
Endocrinology
Top 10 Co-Authors
Michinori Hirata
Naoshi Fukushima
Koichi Endo
Masafumi Fukagawa
Kenichiro Kusano
Junko Hashimoto
Masako Ito
Nobuo Nagano
Masataka Kuwana
Katsuhisa Yamashita
Published In
Nephrol Dial Transplant
Mod Rheumatol
Kidney Int
J Bone Miner Metab
Affiliations
Soon will be listed here.
Recent Articles
1.
Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial
Kuwana M, Takehara K, Tanaka Y, Yamashita K, Katsumata K, Takata M, et al.
Mod Rheumatol . 2023 Jul; 34(3):530-540. PMID: 37436828
Objectives: The aim of this article is to investigate the efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis. Methods: Post hoc subgroup analysis of a global, randomised,...
2.
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study
Hagino H, Ito M, Hashimoto J, Yamamoto M, Endo K, Katsumata K, et al.
J Bone Miner Metab . 2017 Apr; 36(3):336-343. PMID: 28389932
The non-inferiority of oral ibandronate 100 mg to intravenous (i.v.) ibandronate 1 mg in increasing lumbar spine (LS) bone mineral density (BMD) after 12 months of treatment was demonstrated in...
3.
In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3
Hirata M, Katsumata K, Endo K, Fukushima N, Ohkawa H, Fukagawa M
Nephrol Dial Transplant . 2003 Aug; 18(9):1770-6. PMID: 12937223
Background: Although it effectively suppresses parathyroid hormone (PTH) secretion, vitamin D [1,25(OH)(2)D(3)] therapy often causes tissue calcification over the long term. In patients on chronic dialysis, cardiovascular calcification is clearly...
4.
Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats
Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke S, et al.
Kidney Int . 2003 Jul; 64(2):441-50. PMID: 12846739
Background: Hyperphosphatemia is associated with severe complications, including ectopic calcification of soft tissues, secondary hyperparathyroidism, and renal osteodystrophy (ROD). Sevelamer hydrochloride is a nonabsorbed calcium- and metal-free phosphate binder that...
5.
22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats
Hirata M, Makibayashi K, Katsumata K, Kusano K, Watanabe T, Fukushima N, et al.
Nephrol Dial Transplant . 2002 Nov; 17(12):2132-7. PMID: 12454223
Background: 22-Oxacalcitriol (OCT), an analogue of vitamin D, has been shown to inhibit cell proliferation in cultured mesangial cells. OCT also prevented albuminuria and glomerular injury in an acute model...
6.
A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action
Hirata M, Endo K, Katsumata K, Ichikawa F, Kubodera N, Fukagawa M
Nephrol Dial Transplant . 2002 Oct; 17 Suppl 10:41-5. PMID: 12386268
Background: Since Slatopolsky et al. (J Clin Invest 1984; 74: 2136-2143) reported the effect of active vitamin D, 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), on secondary hyperparathyroidism (2HPT) which accompanies chronic renal failure,...